Target Corporation (NYSE: TGT), one of America’s largest and most established retail chains, is once again drawing attention from analysts and institutional investors. With improving earnings forecasts, mixed but leaning-positive analyst sentiment, and potential upside in the stock price, investors are asking whether now is the right time to buy. Here’s what the data reveals.

Average Price Target: $104.73 – Upside of 11.08%

According to forecasts from 30 leading analysts, the average one-year price target for Target stock is $104.73, representing an 11.08% increase from the current price of $94.29. Expectations vary significantly, with the most optimistic projection reaching $155 (a +64.39% increase), while the most conservative forecast calls for a decline to $80, reflecting a potential downside of -15.16%.

Analyst Consensus: Buy – Majority Lean Toward Hold

Over the past three months, 39 analysts have issued ratings for TGT. The consensus remains cautiously optimistic: 11 analysts rated it a “Strong Buy,” while 25 recommended holding. Only 2 analysts issued sell recommendations, with just one labeling it a “Strong Sell.” Overall, the stock is positioned in the “Buy” category on the sentiment meter, signaling moderate confidence relative to peers in the retail sector.

EPS Forecast: Earnings Set to Rebound from 2026

Following a steep drop in 2022, when earnings per share (EPS) fell to $6.02, Target rebounded to $8.94 in 2023. EPS for 2024 is estimated at $8.86, with future forecasts suggesting continued growth: $7.47 in 2025, climbing to $8.17 in 2026 and $8.89 by 2028. The company has consistently outperformed expectations, with EPS surprises of +6.67% in 2023 and +8.99% in 2022.

Revenue Outlook: Stable, Not Explosive

In 2023, Target posted revenue of $107.41 billion, slightly above the estimate of $107.22 billion. For 2024, projected revenue stands at $106.32 billion, with a gradual climb forecasted through 2028, reaching $112.49 billion. This suggests that revenue growth is modest, and earnings improvements are more likely to come from margin optimization rather than top-line expansion.

Latest Analyst Ratings: Mixed Signals with Upside Potential

Greg Melich of Evercore ISI revised his target from $120 to $100, maintained a “Hold” rating, and projected a 6.06% upside.

Paul Lejuez from Citi set a target of $94, slightly below current levels, implying a -0.31% downside.

Joe Feldman at Telsey Advisory downgraded the stock from $130 to $110, yet still anticipates a 16.66% upside.

Scot Ciccarelli of Truist Financial raised his target from $82 to $90, reiterated a “Hold,” and sees a -4.55% downside.

Peter Benedict from Robert W. Baird reaffirmed his “Buy” rating with a $100 target, representing a 6.06% upside.

Edward Kelly from Wells Fargo is the most bullish, upgrading his target to $115, suggesting a 21.96% upside—currently the most aggressive projection among top analysts.

What’s Driving the Ratings?

The prevailing analyst sentiment is based on a combination of margin stabilization, solid sales figures, and disciplined cost control. Target’s resilience in volatile periods gives it a competitive edge over other discount retailers. However, concerns remain around operating costs and overall profitability pressure in the current inflationary climate.

Is Now the Time to Invest?

Is Target stock a buy, or is caution still warranted? Based on current pricing and future earnings potential, the stock appears moderately undervalued. While macroeconomic headwinds persist, Target has demonstrated gradual recovery and has retained investor confidence, albeit cautiously.

Bottom Line

With an average upside of 11%, an improving EPS outlook, and a general “Buy” rating from analysts, Target appears to be stabilizing. Yet, the overall tone remains measured. For investors seeking a blend of stability and moderate growth potential, TGT represents a solid medium- to long-term position—especially when factoring in its consistent dividend payouts.


Comparison, examination, and analysis between investment houses

Leave your details, and an expert from our team will get back to you as soon as possible

    * This article, in whole or in part, does not contain any promise of investment returns, nor does it constitute professional advice to make investments in any particular field.

    To read more about the full disclaimer, click here
    PAKISTAN AND US REACH A TRADE AGREEMENT TO DEVELOP OIL RESERVES AND REDUCE TARIFFS
    • orshu
    • 9 Min Read
    • ago 10 minutes

    PAKISTAN AND US REACH A TRADE AGREEMENT TO DEVELOP OIL RESERVES AND REDUCE TARIFFS PAKISTAN AND US REACH A TRADE AGREEMENT TO DEVELOP OIL RESERVES AND REDUCE TARIFFS

    Pakistan and US Forge Trade Agreement on Oil Reserves and Tariffs   A recent trade agreement between Pakistan and the

    • ago 10 minutes
    • 9 Min Read

    Pakistan and US Forge Trade Agreement on Oil Reserves and Tariffs   A recent trade agreement between Pakistan and the

    European Markets Close Mixed as Trade Tensions and Earnings Season Weigh In
    • orshu
    • 9 Min Read
    • ago 2 hours

    European Markets Close Mixed as Trade Tensions and Earnings Season Weigh In European Markets Close Mixed as Trade Tensions and Earnings Season Weigh In

    Europe's major stock indices concluded the trading day with a mixed performance, reflecting investor reactions to a busy earnings season

    • ago 2 hours
    • 9 Min Read

    Europe's major stock indices concluded the trading day with a mixed performance, reflecting investor reactions to a busy earnings season

    BIOGEN RAISES ANNUAL PROFIT FORECAST ON STRONG DEMAND FOR RARE DISEASE DRUGS
    • orshu
    • 6 Min Read
    • ago 3 hours

    BIOGEN RAISES ANNUAL PROFIT FORECAST ON STRONG DEMAND FOR RARE DISEASE DRUGS BIOGEN RAISES ANNUAL PROFIT FORECAST ON STRONG DEMAND FOR RARE DISEASE DRUGS

    Biogen's Performance Driven by Rare Disease Drugs   Biogen is seeing a significant boost in its financial performance due to

    • ago 3 hours
    • 6 Min Read

    Biogen's Performance Driven by Rare Disease Drugs   Biogen is seeing a significant boost in its financial performance due to

    Americas Market Snapshot: Navigating Mixed Signals on July 31, 2025
    • orshu
    • 8 Min Read
    • ago 4 hours

    Americas Market Snapshot: Navigating Mixed Signals on July 31, 2025 Americas Market Snapshot: Navigating Mixed Signals on July 31, 2025

    Introduction As of Thursday, July 31, 2025, the Americas markets are presenting a mixed bag of performance, with some key

    • ago 4 hours
    • 8 Min Read

    Introduction As of Thursday, July 31, 2025, the Americas markets are presenting a mixed bag of performance, with some key